DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE

According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosph...

Full description

Saved in:
Bibliographic Details
Main Authors HORI, NOBUYUKI, HORIBA, NAOSHI, HARADA, TAKEO, KASWIWAGI, HIROTAKA, MURATA, YOSHIHISA, ONO, YOSHIYUKI, OHTOMO, SHUICHI, OKAMOTO, NAOKI, TACHIBANA, KAZUTAKA, IDE, MITSUAKI, MIZUGUCHI, EISAKU, ICHIDA, YASUHIRO, OHTAKE, YOSHIHITO, KIMBARA, ATSUSHI, NOMURA, KENICHI, TANAKA, SHOTA
Format Patent
LanguageEnglish
Spanish
Published 10.02.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and/or therapeutic agent as well as a prophylactic and/or therapeutic method for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure. La presente invención proporciona un derivado de dihidropiridazin-3,5-diona o una sal del mismo, o un solvato del compuesto o la sal, un fármaco farmacéutico, una composición farmacéutica, un inhibidor del transportador de fosfato dependiente de sodio y un agente de prevención y/o terapéutico para la hiperfosfatemia, hiperparatiroidismo secundario, e insuficiencia renal crónica, que comprende el compuesto como un ingrediente activo, y un método para la prevención y/o tratamiento.
AbstractList According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and/or therapeutic agent as well as a prophylactic and/or therapeutic method for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure. La presente invención proporciona un derivado de dihidropiridazin-3,5-diona o una sal del mismo, o un solvato del compuesto o la sal, un fármaco farmacéutico, una composición farmacéutica, un inhibidor del transportador de fosfato dependiente de sodio y un agente de prevención y/o terapéutico para la hiperfosfatemia, hiperparatiroidismo secundario, e insuficiencia renal crónica, que comprende el compuesto como un ingrediente activo, y un método para la prevención y/o tratamiento.
Author HORIBA, NAOSHI
OHTOMO, SHUICHI
HARADA, TAKEO
OKAMOTO, NAOKI
ONO, YOSHIYUKI
MURATA, YOSHIHISA
KASWIWAGI, HIROTAKA
IDE, MITSUAKI
OHTAKE, YOSHIHITO
KIMBARA, ATSUSHI
ICHIDA, YASUHIRO
TACHIBANA, KAZUTAKA
MIZUGUCHI, EISAKU
HORI, NOBUYUKI
TANAKA, SHOTA
NOMURA, KENICHI
Author_xml – fullname: HORI, NOBUYUKI
– fullname: HORIBA, NAOSHI
– fullname: HARADA, TAKEO
– fullname: KASWIWAGI, HIROTAKA
– fullname: MURATA, YOSHIHISA
– fullname: ONO, YOSHIYUKI
– fullname: OHTOMO, SHUICHI
– fullname: OKAMOTO, NAOKI
– fullname: TACHIBANA, KAZUTAKA
– fullname: IDE, MITSUAKI
– fullname: MIZUGUCHI, EISAKU
– fullname: ICHIDA, YASUHIRO
– fullname: OHTAKE, YOSHIHITO
– fullname: KIMBARA, ATSUSHI
– fullname: NOMURA, KENICHI
– fullname: TANAKA, SHOTA
BookMark eNrjYmDJy89L5WRQc_H0iHQJ8g-IDPJ0cYzy9HPVNdYx1XXx9PdzVXBxDfIMcwzxDHPlYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoamBoZGpsbmjsZEKQIA9-0lyw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DERIVADOS DE DIHIDROPIRIDAZIN-3,5-DIONA.
ExternalDocumentID MX2015012537A
GroupedDBID EVB
ID FETCH-epo_espacenet_MX2015012537A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:48:31 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MX2015012537A3
Notes Application Number: MX20150012537
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160210&DB=EPODOC&CC=MX&NR=2015012537A
ParticipantIDs epo_espacenet_MX2015012537A
PublicationCentury 2000
PublicationDate 20160210
PublicationDateYYYYMMDD 2016-02-10
PublicationDate_xml – month: 02
  year: 2016
  text: 20160210
  day: 10
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies CHUGAI SEIYAKU KABUSHIKI KAISHA
RelatedCompanies_xml – name: CHUGAI SEIYAKU KABUSHIKI KAISHA
Score 2.8855243
Snippet According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160210&DB=EPODOC&locale=&CC=MX&NR=2015012537A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOZYj0yeJmmtY-FOmallboB6WWzpfR1gxE0GEr_vteQqd72lvIQT4Ofnf5JZc7gJtxSbjJzVIV2exECbNKRQpWqpXBa_KKHnwh7zvCSPeftaeCFj14X_2FkXlCf2RyRERUjXhvpb1e_l9iMRlb2dxVb9j1-ehlFlM6djzRBYVR2NRyk5jFjuI4VlgoUSpkFG0xJYa9Bdt4jjYEHNx8Kr6lLNd9incAOwkO99EeQo83A9hzVqXXBrAbdi_e2OzA1xyBwgJ_xtI4maUBs1-CyFXJLVUZWkN3xJCQ5XYW5O4xXHtu5vgqTjj_2948LNYWR06gj7yfn8II-yrOqUm5TjTtvjQfkDmSCbrY2iyNBT-D4YaBzjdKh7AvtCXCjyfjC-i3X9_8Er1rW11JrfwCPv54ig
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rRq1PhpjOEksbgE5EENZCGh5hCChvRDAbWJMtBGMf99ZQrWn3jY7yT4m-Wb2252dAbgZ5YRpTMtFns2OlzArRKRguViorCSv6MEXzX2H5yvOy_gpldMOvK_-wjR5Qn-a5IiIqBLxXjf2evl_iUWb2MrqrnjDrs9HO9ap0LJjSeEURqAT3QoDGpiCaepeKvgRl8loi2WiGluwjWdslcPBSib8W8py3afY-7AT4nAf9QF0WNWHnrkqvdaHXa998cZmC77qEATqOjMaBeEscqkxd31LJLeySNEaWkOKhCwxYjexjuDatmLTEXHC7G97mZeuLY4cQxd5PzuBIfYVjMmazBQyHt_n2gMyRyKhiy21XF2wUxhsGOhso_QKek7sTbOp6z8PYI9rjociS6Nz6NZf3-wCPW1dXDYa-gURVHt9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DIHYDROPYRIDAZINE-3%2C5-DIONE+DERIVATIVE&rft.inventor=HORI%2C+NOBUYUKI&rft.inventor=HORIBA%2C+NAOSHI&rft.inventor=HARADA%2C+TAKEO&rft.inventor=KASWIWAGI%2C+HIROTAKA&rft.inventor=MURATA%2C+YOSHIHISA&rft.inventor=ONO%2C+YOSHIYUKI&rft.inventor=OHTOMO%2C+SHUICHI&rft.inventor=OKAMOTO%2C+NAOKI&rft.inventor=TACHIBANA%2C+KAZUTAKA&rft.inventor=IDE%2C+MITSUAKI&rft.inventor=MIZUGUCHI%2C+EISAKU&rft.inventor=ICHIDA%2C+YASUHIRO&rft.inventor=OHTAKE%2C+YOSHIHITO&rft.inventor=KIMBARA%2C+ATSUSHI&rft.inventor=NOMURA%2C+KENICHI&rft.inventor=TANAKA%2C+SHOTA&rft.date=2016-02-10&rft.externalDBID=A&rft.externalDocID=MX2015012537A